M&A Deal Summary

Catalent Acquires Cook Group

On September 19, 2017, Catalent acquired medical products company Cook Group for 950M USD

Acquisition Highlights
  • This is Catalent’s 3rd transaction in the Medical Products sector.
  • This is Catalent’s 3rd largest (disclosed) transaction.
  • This is Catalent’s 4th transaction in the United States.
  • This is Catalent’s 1st transaction in Indiana.

M&A Deal Summary
Date 2017-09-19
Target Cook Group
Sector Medical Products
Buyer(s) Catalent
Deal Type Add-on Acquisition
Deal Value 950M USD

Target

Cook Group

Bloomington, Indiana, United States
Cook Group, Inc. (Cook Pharmica LLC) is a biologics-focused contract development and manufacturing organization with capabilities across biologics development, clinical and commercial cell culture manufacturing, formulation, finished-dose manufacturing, and packaging. Cook Pharmica LLC was established in 2004 and is based in Bloomington, Indiana.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Catalent

Somerset, New Jersey, United States
Category Company
Founded 2007
Sector Life Science
Revenue 4.3B USD (2023)
DESCRIPTION

Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.

DEAL STATS #
Overall 6 of 16
Sector (Medical Products) 3 of 3
Type (Add-on Acquisition) 6 of 10
State (Indiana) 1 of 1
Country (United States) 4 of 9
Year (2017) 1 of 1
Size (of disclosed) 3 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-28 Accucaps Industries

Windsor, Ontario, Canada

Accucaps Industries Ltd. is a developer and manufacturer of Over-the-Counter (OTC), high potency and conventional pharmaceutical softgels.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-07-03 Juniper Pharmaceuticals

Boston, Massachusetts, United States

Juniper Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women’s health. Juniper Pharmaceuticals was founded in 1986 and is based in Boston, Massachusetts.

Buy -
Mergr

Product

Company

Legal